GENEVA, 24 June 2025 —Cambodia has strengthened their joint efforts to combat the AIDS pandemic by signing a new cooperation ...

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of vaccines can coax the immune system to produce powerful ...

Who is being left behind? – herald Tawanda Musarurwa Check Point Desk “EVEN when people know about HIV and take risks, there are still many reasons why some men might not go for testing. “Sometimes it ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of vaccines can coax the immune system to produce powerful ...

Watch the NACO Sensitization Programme on HIV/AIDS, featuring esteemed members of the Tripura Legislative Forum on AIDS. The ...

World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able ...

Analysts at Citi said that while the clinical hold impacts the targeted commercial launch of the GS-1720/GS-4182 regimen, previously expected around 2029/2030, they believe the setback is minor, as it ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of vaccines can coax the immune system to produce powerful ...

Reports of HIV remissions have researchers optimistic that a cure is possible one day. ... The London patient, who is anonymous, had no signs of HIV after the stem cell transplant.

It trades at 13.3 times forward earnings—below the industry average of 14, as measured by the NYSE Arca Pharmaceutical Index, and hardly a stretch for a company on the cusp of a new product cycle.